Name
DRONTAL MULTI FLAVOR MEAT XL 525/504/175 MG TABLETS FOR DOGS
Category
Anthelmintics, praziquantel combinations.
Active ingredients
Each tablet contains the active ingredients: 525 mg febantel; 175 mg pyrantel equivalent to 504 mg pyrantel embonate; 175 mg praziquantel. Excipients: For a full list of excipients, see section 6.1.
Directions
Treatment of mixed infections by nematodes and cestodes of the following species. Nematodes: Ascarids (adults and late immature forms): Toxocara canis, Toxascaris leonina; Hookworms (adults): Uncinaria stenocephala, Ancylostoma caninum; Whipworms (adults): Trichuris vulpis. Cestodes (adults and immature forms): Echinococcus granulosus; Echinococcus multilocularis; Dipylidium caninum; Taenia spp.
Dosage
For oral administration only. Dosage: For the treatment of dogs: 1 tablet per 35 kg of body weight (15 mg febantel, 14.4 mg pyrantel embonate, and 5 mg praziquantel/kg of body weight). Dosages are as follows: Body weight: 7-17.5 kg; number of tablets: 1/2. Body weight: >17.5-35 kg; number of tablets: 1. Body weight: >35-52.5 kg; number of tablets: 1 1/2. Body weight: 52.5-70 kg; number of tablets: 2. For every additional 17.5 kg of body weight, administer an additional 1/2 tablet. Administration and duration of treatment: The tablets are flavored and studies have shown that they are palatable and are taken spontaneously by the majority (88%) of dogs tested. The tablets can be administered with or without food. It is not necessary to restrict access to a normal diet before or after treatment. The tablets should be administered as a single dose. After opening the blister, any remaining halved tablets should be discarded immediately or returned to the opened blister until use. Consult a veterinarian regarding the need and frequency of repeat treatment. Do not use in dogs weighing less than 7 kg.
Conservation
This veterinary medicinal product does not require any special storage conditions. Shelf life of the veterinary medicinal product as packaged for sale: 3 years. Shelf life of halved tablets: 7 days.
Pregnancy and breastfeeding
Teratogenic effects attributed to high doses of febantel administered during early pregnancy have been reported in rats, sheep, and dogs. The safety of the product has not been studied during the first and second thirds of pregnancy. Do not use in pregnant dogs during the first and second thirds of pregnancy (see section 4.3). A single treatment during the last third of pregnancy or during lactation has been shown to be safe.